GENEWIZ is a leading provider of genomics services to over 4,000 institutional customers worldwide, enabling research scientists to advance their discoveries faster than ever before. A Brooks Life Sciences company, GENEWIZ leads the industry with our unique and proprietary technologies backed by specialized experts in Sanger sequencing, gene synthesis, next generation sequencing, and GLP/CLIA regulatory-compliant services.